Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Veracyte (VCYT) Net Margin (2016 - 2025)

Historic Net Margin for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to 14.51%.

  • Veracyte's Net Margin rose 14400.0% to 14.51% in Q3 2025 from the same period last year, while for Sep 2025 it was 6.12%, marking a year-over-year increase of 83000.0%. This contributed to the annual value of 5.41% for FY2024, which is 260200.0% up from last year.
  • According to the latest figures from Q3 2025, Veracyte's Net Margin is 14.51%, which was up 14400.0% from 0.75% recorded in Q2 2025.
  • Veracyte's Net Margin's 5-year high stood at 14.51% during Q3 2025, with a 5-year trough of 114.06% in Q1 2021.
  • For the 5-year period, Veracyte's Net Margin averaged around 13.7%, with its median value being 9.82% (2023).
  • As far as peak fluctuations go, Veracyte's Net Margin tumbled by -764100bps in 2021, and later soared by 927200bps in 2022.
  • Quarter analysis of 5 years shows Veracyte's Net Margin stood at 15.62% in 2021, then surged by 69bps to 4.82% in 2022, then plummeted by -497bps to 28.81% in 2023, then soared by 115bps to 4.33% in 2024, then surged by 235bps to 14.51% in 2025.
  • Its Net Margin stands at 14.51% for Q3 2025, versus 0.75% for Q2 2025 and 6.14% for Q1 2025.